• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型生物制剂治疗银屑病的免疫学基础。

The immunologic basis for the treatment of psoriasis with new biologic agents.

作者信息

Krueger James G

机构信息

Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY 10021-6399, USA.

出版信息

J Am Acad Dermatol. 2002 Jan;46(1):1-23; quiz 23-6. doi: 10.1067/mjd.2002.120568.

DOI:10.1067/mjd.2002.120568
PMID:11756941
Abstract

Psoriasis vulgaris is the most prevalent T-cell-mediated inflammatory disease in humans. The pathogenesis of psoriasis is linked to activation of several types of leukocytes that control cellular immunity and to a T-cell-dependent inflammatory process in skin that accelerates the growth of epidermal and vascular cells in psoriasis lesions. Critical steps in immunologic activation include Langerhans cell maturation (activation), T-cell activation, differentiation and expansion of type 1 T cells, selective trafficking of activated T cells to skin, and induction of an inflammatory cytokine and chemokine cascade in skin lesions. In turn, each of these steps offers an opportunity for intervention with engineered biologic therapeutics.

摘要

寻常型银屑病是人类中最常见的T细胞介导的炎症性疾病。银屑病的发病机制与控制细胞免疫的几种白细胞的激活以及皮肤中T细胞依赖性炎症过程有关,该炎症过程加速了银屑病皮损中表皮细胞和血管细胞的生长。免疫激活的关键步骤包括朗格汉斯细胞成熟(激活)、T细胞激活、1型T细胞的分化和扩增、活化T细胞向皮肤的选择性迁移以及皮损中炎症细胞因子和趋化因子级联反应的诱导。反过来,这些步骤中的每一个都为使用工程生物疗法进行干预提供了机会。

相似文献

1
The immunologic basis for the treatment of psoriasis with new biologic agents.新型生物制剂治疗银屑病的免疫学基础。
J Am Acad Dermatol. 2002 Jan;46(1):1-23; quiz 23-6. doi: 10.1067/mjd.2002.120568.
2
Immunopathogenesis of psoriasis.银屑病的免疫发病机制
Australas J Dermatol. 2006 Aug;47(3):151-9. doi: 10.1111/j.1440-0960.2006.00262.x.
3
The immunology of psoriasis and biologic immunotherapy.银屑病的免疫学与生物免疫疗法
J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S44-50. doi: 10.1016/s0190-9622(03)01134-4.
4
Psoriasis and the new biologic agents: interrupting a T-AP dance.银屑病与新型生物制剂:阻断T-AP之舞
CMAJ. 2004 Jun 22;170(13):1933-41. doi: 10.1503/cmaj.1031335.
5
Psoriasis as a T cell-mediated autoimmune disease.银屑病是一种由T细胞介导的自身免疫性疾病。
Hosp Med. 1998 Jul;59(7):530-3.
6
The role of dendritic cells in the immunopathogenesis of psoriasis.树突状细胞在银屑病免疫发病机制中的作用。
Arch Dermatol Res. 2007 Oct;299(8):359-66. doi: 10.1007/s00403-007-0775-4. Epub 2007 Aug 7.
7
Psoriasis. Leukocytes and cytokines.银屑病。白细胞与细胞因子。
Dermatol Clin. 1990 Oct;8(4):737-45.
8
Immunopathogenesis and immunotherapy of psoriasis.银屑病的免疫发病机制与免疫治疗
Dermatol Clin. 1995 Oct;13(4):739-49.
9
Cytotoxic T lymphocytes as a potential brake of keratinocyte proliferation in psoriasis.细胞毒性T淋巴细胞作为银屑病中角质形成细胞增殖的潜在抑制因素。
Med Hypotheses. 2016 Feb;87:66-8. doi: 10.1016/j.mehy.2015.12.004. Epub 2015 Dec 12.
10
Novel immunotherapies for psoriasis.银屑病的新型免疫疗法。
Trends Immunol. 2002 Jan;23(1):47-53. doi: 10.1016/s1471-4906(01)02119-6.

引用本文的文献

1
Cutaneous Adverse Events Following Nemolizumab Administration: A Review.奈莫利珠单抗给药后的皮肤不良事件:综述
J Clin Med. 2025 Apr 27;14(9):3026. doi: 10.3390/jcm14093026.
2
Challenges Psoriasis and Its Impact on Quality of Life: Challenges in Treatment and Management.银屑病的挑战及其对生活质量的影响:治疗与管理中的挑战
Psoriasis (Auckl). 2025 May 1;15:175-183. doi: 10.2147/PTT.S519420. eCollection 2025.
3
The Role of Metabolic Syndrome in Psoriasis Treatment Response: A One-Year Comparative Analysis of PASI Progression.
代谢综合征在银屑病治疗反应中的作用:一项关于银屑病面积和严重程度指数(PASI)进展的一年期比较分析
Diagnostics (Basel). 2024 Dec 23;14(24):2887. doi: 10.3390/diagnostics14242887.
4
The Immunology of Psoriasis-Current Concepts in Pathogenesis.《银屑病的免疫学——发病机制的当前概念》。
Clin Rev Allergy Immunol. 2024 Apr;66(2):164-191. doi: 10.1007/s12016-024-08991-7. Epub 2024 Apr 20.
5
Bibliometric analysis and description of research trends on T cells in psoriasis over the past two decades (2003-2022).过去二十年(2003 - 2022年)银屑病中T细胞研究趋势的文献计量分析与描述
Heliyon. 2023 Dec 10;10(1):e23542. doi: 10.1016/j.heliyon.2023.e23542. eCollection 2024 Jan 15.
6
Targeting T-cell integrins in autoimmune and inflammatory diseases.靶向自身免疫和炎症性疾病中的 T 细胞整合素。
Clin Exp Immunol. 2024 Jan 9;215(1):15-26. doi: 10.1093/cei/uxad093.
7
Research Hotspots in Psoriasis: A Bibliometric Study of the Top 100 Most Cited Articles.银屑病的研究热点:对100篇被引频次最高文章的文献计量学研究
Healthcare (Basel). 2023 Jun 26;11(13):1849. doi: 10.3390/healthcare11131849.
8
Nanoscale Topical Pharmacotherapy in Management of Psoriasis: Contemporary Research and Scope.纳米级局部药物疗法在银屑病治疗中的应用:当代研究与展望
J Funct Biomater. 2022 Dec 29;14(1):19. doi: 10.3390/jfb14010019.
9
Novel concepts in psoriasis: histopathology and markers related to modern treatment approaches.银屑病的新概念:与现代治疗方法相关的组织病理学和标志物。
Rom J Morphol Embryol. 2021 Oct-Dec;62(4):897-906. doi: 10.47162/RJME.62.4.02.
10
A prevalence and molecular characterization of novel pathogenic strains of Macrococcus caseolyticus isolated from external wounds of donkeys in Khartoum State -Sudan.从苏丹喀土穆州驴的外部伤口中分离出的新型致病性巨球菌的流行情况和分子特征。
BMC Vet Res. 2022 May 25;18(1):197. doi: 10.1186/s12917-022-03297-2.